Zepp Health Corp(ZEPP)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Limited institutional coverage
Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 36 institutional filers currently hold this stock.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
ZEPP Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Zepp Health Corp (ZEPP), a Technology sector company. ZEPP is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 36 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2025), Zepp Health Corp reports quarterly revenue of $258.9M, net income of $-40.1M, free cash flow of $-26.2M. Top institutional holders of ZEPP by reported 13-F value include FIL Ltd, MORGAN STANLEY, Point72 Asset Management, L.P., based on the most recent SEC filings. ZEPP trades on the NYSE exchange and files with the SEC under CIK 1720446. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ZEPP daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Zepp Health Corp directly from SEC EDGAR.
Revenue
FY 2025
$258.9M
Net Income
FY 2025
$-40.1M
Free Cash Flow
FY 2025
$-26.2M
ROIC
FY 2025
-10.7%
D/E Ratio
FY 2025
0.28
AI Insight: ZEPP Financial Trends
Equity collapsed 91% from $2.9B in Q4 2021 to $215M in Q4 2025, while debt decreased modestly.
• Equity plummeted from $2,920M in Q4 2021 to $215M in Q4 2025, an 91% decline over four years.
• Total debt decreased from $120M in Q4 2023 to $59M in Q4 2025, declining 51% over two years.
⚠ Equity continues eroding with $37M decline from Q4 2024 to Q4 2025, indicating ongoing financial stress.
AI Insight: ZEPP Ratio Trends
Data is too sparse to identify meaningful trends with only debt-to-equity ratios available across the time series.
• Debt-to-equity ratio jumped from 0.05 in Q4 2023 to 0.30 in Q4 2024, then declined slightly to 0.28 in Q4 2025.
⚠ The significant leverage increase in Q4 2024 requires monitoring for impact on financial flexibility and returns.
Get alerted when ZEPP's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Zepp Health Corp including:
Top Institutional Holders of ZEPP
FIL Ltd
$8.6M717,352 shMORGAN STANLEY
$8.5M707,691 shPoint72 Asset Management, L.P.
$6.9M577,676 shMILLENNIUM MANAGEMENT LLC
$4.1M342,504 shMonolith Management Ltd
$2.1M173,847 shSTATE STREET CORP
$1.5M127,108 shGOLDMAN SACHS GROUP INC
$1.4M117,804 shBALYASNY ASSET MANAGEMENT L.P.
$804.6K67,328 shYiheng Capital Management, L.P.
$689.9K57,731 shAllspring Global Investments Holdings, LLC
$558.6K46,748 sh
| Fund | Value | Shares |
|---|---|---|
| FIL Ltd | $8.6M | 717,352 |
| MORGAN STANLEY | $8.5M | 707,691 |
| Point72 Asset Management, L.P. | $6.9M | 577,676 |
| MILLENNIUM MANAGEMENT LLC | $4.1M | 342,504 |
| Monolith Management Ltd | $2.1M | 173,847 |
| STATE STREET CORP | $1.5M | 127,108 |
| GOLDMAN SACHS GROUP INC | $1.4M | 117,804 |
| BALYASNY ASSET MANAGEMENT L.P. | $804.6K | 67,328 |
| Yiheng Capital Management, L.P. | $689.9K | 57,731 |
| Allspring Global Investments Holdings, LLC | $558.6K | 46,748 |
More Technology Companies
View all Technology →Put ZEPP on your watchlist
Track score changes the day Zepp Health Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ZEPP a good stock to buy?
13F Pro's AI-powered analysis of Zepp Health Corp (ZEPP) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ZEPP are available on the ZEPP stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own ZEPP?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ZEPP. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Zepp Health Corp's investment landscape.